143 related articles for article (PubMed ID: 38131136)
1. Novel computational and drug design strategies for the inhibition of human T-cell leukemia virus 1-associated lymphoma by Astilbin derivatives.
Akash S; Mahmood S; Ahamed R; Bayıl I; Dev Bairagi R; Islam MR; Hosen ME; de Lima Menezes G; S Almaary K; Nafidi HA; Bourhia M; Ouahmane L
J Biomol Struct Dyn; 2023 Dec; ():1-16. PubMed ID: 38131136
[TBL] [Abstract][Full Text] [Related]
2. Identification of Helicobacter pylori-carcinogenic TNF-alpha-inducing protein inhibitors via daidzein derivatives through computational approaches.
Tayyeb JZ; Mondal S; Anisur Rahman M; Kumar S; Bayıl I; Akash S; Hossain MS; Alqahtani T; Zaki MEA; Oliveira JIN
J Cell Mol Med; 2024 May; 28(9):e18358. PubMed ID: 38693868
[TBL] [Abstract][Full Text] [Related]
3. The molecular docking and molecular dynamics study of flavonol synthase and flavonoid 3'-monooxygenase enzymes involved for the enrichment of kaempferol.
Kumari G; Nigam VK; Pandey DM
J Biomol Struct Dyn; 2023 Apr; 41(6):2478-2491. PubMed ID: 35105279
[TBL] [Abstract][Full Text] [Related]
4. Exploring the interaction mechanism between potential inhibitor and multi-target Mur enzymes of mycobacterium tuberculosis using molecular docking, molecular dynamics simulation, principal component analysis, free energy landscape, dynamic cross-correlation matrices, vector movements, and binding free energy calculation.
Kumari M; Singh R; Subbarao N
J Biomol Struct Dyn; 2022; 40(24):13497-13526. PubMed ID: 34662260
[TBL] [Abstract][Full Text] [Related]
5. Repurposing antiviral drugs against HTLV-1 protease by molecular docking and molecular dynamics simulation.
Jahantigh H; Ahmadi N; Lovreglio P; Stufano A; Enayatkhani M; Shahbazi B; Ahmadi K
J Biomol Struct Dyn; 2023 Jul; 41(11):5057-5066. PubMed ID: 35612907
[TBL] [Abstract][Full Text] [Related]
6. Molecular dynamics and absolute binding free energy studies of piperine derivatives as potential inhibitors of SARS-CoV-2 main protease.
Amperayani KR; Varadhi G; Oruganti B; Parimi UD
J Biomol Struct Dyn; 2023; 41(23):13696-13706. PubMed ID: 36995111
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and bioevaluation of novel unsaturated cyanoacetamide derivatives: In vitro and in silico exploration.
Uddin KM; Meem MH; Akter M; Rahman S; Al-Gawati MA; Alarifi N; Albrithen H; Alodhayb A; Poirier RA; Bhuiyan MMH
MethodsX; 2024 Jun; 12():102691. PubMed ID: 38660042
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and molecular dynamics simulation studies of quinoline derivatives as protease inhibitors against SARS-CoV-2.
Singh VK; Chaurasia H; Kumari P; Som A; Mishra R; Srivastava R; Naaz F; Singh A; Singh RK
J Biomol Struct Dyn; 2022; 40(21):10519-10542. PubMed ID: 34253149
[TBL] [Abstract][Full Text] [Related]
9. Computational prediction for designing novel ketonic derivatives as potential inhibitors for breast cancer: A trade-off between drug likeness and inhibition potency.
Muhammad S; Zahir N; Bibi S; Alshahrani MY; Shafiq-urRehman ; Chaudhry AR; Sarwar F; Tousif MI
Comput Biol Chem; 2024 Apr; 109():108020. PubMed ID: 38286082
[TBL] [Abstract][Full Text] [Related]
10. Probing intermolecular interactions and binding stability of kaempferol, quercetin and resveratrol derivatives with PPAR-γ: docking, molecular dynamics and MM/GBSA approach to reveal potent PPAR- γ agonist against cancer.
Lokhande KB; Ballav S; Yadav RS; Swamy KV; Basu S
J Biomol Struct Dyn; 2022 Feb; 40(3):971-981. PubMed ID: 32954977
[TBL] [Abstract][Full Text] [Related]
11. Antimalarial drug discovery against malaria parasites through haplopine modification: An advanced computational approach.
Akash S; Abdelkrim G; Bayil I; Hosen ME; Mukerjee N; Shater AF; Saleh FM; Albadrani GM; Al-Ghadi MQ; Abdel-Daim MM; Tok TT
J Cell Mol Med; 2023 Oct; 27(20):3168-3188. PubMed ID: 37724615
[TBL] [Abstract][Full Text] [Related]
12. Developing Hispolon-based novel anticancer therapeutics against human (NF-κβ) using
Paul M; Kumar Panda M; Thatoi H
J Biomol Struct Dyn; 2019 Sep; 37(15):3947-3967. PubMed ID: 30295165
[TBL] [Abstract][Full Text] [Related]
13.
Jahantigh HR; Stufano A; Lovreglio P; Rezaee SA; Ahmadi K
J Biomol Struct Dyn; 2022 Sep; 40(15):6737-6754. PubMed ID: 33648421
[TBL] [Abstract][Full Text] [Related]
14. New molecular insights for 4
Mehta CC; Rohit S; Patel S; Bhatt HG
J Biomol Struct Dyn; 2023; 41(22):13496-13508. PubMed ID: 36755438
[TBL] [Abstract][Full Text] [Related]
15. Investigating the role of N-terminal domain in phosphodiesterase 4B-inhibition by molecular dynamics simulation.
Sharma V; Wakode S
J Biomol Struct Dyn; 2021 Aug; 39(12):4270-4278. PubMed ID: 32552529
[TBL] [Abstract][Full Text] [Related]
16. Protein-protein docking and molecular dynamics studies of sericin and cocoonase of silkworm: an insight for cocoon softening.
Tiwari NP; Pandey JP; Pandey DM
J Biomol Struct Dyn; 2023 Mar; 41(4):1193-1205. PubMed ID: 34939532
[TBL] [Abstract][Full Text] [Related]
17. A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2.
Islam R; Parves MR; Paul AS; Uddin N; Rahman MS; Mamun AA; Hossain MN; Ali MA; Halim MA
J Biomol Struct Dyn; 2021 Jun; 39(9):3213-3224. PubMed ID: 32340562
[TBL] [Abstract][Full Text] [Related]
18. Repurposing integrase inhibitors against human T-lymphotropic virus type-1: a computational approach.
Sinha P; Yadav AK
J Biomol Struct Dyn; 2024 Jan; ():1-12. PubMed ID: 38234060
[TBL] [Abstract][Full Text] [Related]
19. Phytoconstituents from ten natural herbs as potent inhibitors of main protease enzyme of SARS-COV-2:
Kumar N; Singh A; Gulati HK; Bhagat K; Kaur K; Kaur J; Dudhal S; Duggal A; Gulati P; Singh H; Singh JV; Bedi PMS
Phytomed Plus; 2021 Nov; 1(4):100083. PubMed ID: 35403086
[TBL] [Abstract][Full Text] [Related]
20. Repurposing of SARS-CoV-2 compounds against Marburg Virus using MD simulation, mm/GBSA, PCA analysis, and free energy landscape.
Kumar S; Dubey R; Mishra R; Gupta S; Dwivedi VD; Ray S; Jha NK; Verma D; Tsai LW; Dubey NK
J Biomol Struct Dyn; 2024 Mar; ():1-20. PubMed ID: 38450706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
